Shinsuke Taki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shinsuke Taki has a total of 262 co-authors. Here are the top co-authors by number of shared publications:
Shigeaki Hida
Department of Molecular and Cellular Health Sciences Graduate School of Pharmaceutical Sciences, Nagoya City University Japan
16 shared publicationsHideki Sanjo
Department of Molecular and Cellular Immunology Shinshu University School of Medicine Matsumoto Japan
8 shared publicationsTadatsugu Taniguchi
6 shared publications- Takashi Saito
Laboratory of Cell Signaling, RIKEN Center for Integrative Medical Sciences , Yokohama, Kanagawa 230-0045
6 shared publications - Hideki Sanjo
Department of Molecular and Cellular Immunology, Shinshu University School of Medicine , 3-1-1 Asahi, Matsumoto 390-8621
4 shared publications Kouetsu Ogasawara
4 shared publications
Latest Publications
- 7 July 2025
- Published by Wiley in FEBS Letters
- Vol. 599 (18) , 2663-2673
ShcA activation via Tyr573 of the IL‐3/IL‐5/GM‐CSF receptor βc signals for IL‐4 production in mouse primary basophils
Granulocyte macrophage colony‐stimulating factor (GM‐CSF), interleukin (IL)‐3, and IL‐5 signals are transmitted via the shared receptor subunit common β (βc). Earlier studies showed that distinct subdomains and tyrosine residues of βc are connected to specific downstream signaling pathways. However, as most of those pathways are for survival/proliferation, much remains to be learned about how βc transmits signals for effector functions. Here, by reconstituting primary βc‐deficient basophils with βc mutants, we found that the tyrosine 573 of βc was required for recruiting and phosphorylating the adaptor ShcA and IL‐4 production. Furthermore, dominant‐negative ShcA and the ShcA inhibitor idebenone inhibited IL‐4 production but not cell survival. These results provided further insight into how the functional pleiotropy of cytokines is supported by the structure of their receptors.
- 7 July 2025
- Published by Wiley in FEBS Letters
- Vol. 599 (18) , 2663-2673
ShcA activation via Tyr573 of the IL‐3/IL‐5/GM‐CSF receptor βc signals for IL‐4 production in mouse primary basophils
Granulocyte macrophage colony‐stimulating factor (GM‐CSF), interleukin (IL)‐3, and IL‐5 signals are transmitted via the shared receptor subunit common β (βc). Earlier studies showed that distinct subdomains and tyrosine residues of βc are connected to specific downstream signaling pathways. However, as most of those pathways are for survival/proliferation, much remains to be learned about how βc transmits signals for effector functions. Here, by reconstituting primary βc‐deficient basophils with βc mutants, we found that the tyrosine 573 of βc was required for recruiting and phosphorylating the adaptor ShcA and IL‐4 production. Furthermore, dominant‐negative ShcA and the ShcA inhibitor idebenone inhibited IL‐4 production but not cell survival. These results provided further insight into how the functional pleiotropy of cytokines is supported by the structure of their receptors.
- 6 May 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 37 (9) , 543-553
Differential regulation of type I and II interferon signals by the transcription factor interferon regulatory factor-2 for the generation and function of macrophage populations in the liver
Two major macrophage populations in the steady-state liver, resident Kupffer cells (KCs) and monocyte-derived macrophages (MoMFs), contribute crucially to the unique physiological functions of the organ. Much remains to be learned, however, about how the differentiation and functions of these cell populations are regulated. We found here that Ly6C–MHCII+ MoMFs were severely reduced in mice lacking interferon (IFN) regulatory factor-2 (IRF-2) (Irf2–/– mice) but restored to the normal frequencies by introducing type I IFN receptor deficiency, indicating that IRF-2 supports MoMF differentiation through attenuating excess type I IFN signals. On the other hand, Irf2–/– KCs developed normally but lacked MHC class II (MHCII) expression. Similar MHCII deficiency in KCs in Il15–/– and Ifng–/– but not Rag1–/– mice pointed to the role for NK cell-derived IFN-γ. Indeed, MHCII expression on resident KCs in Ifng–/– mice was recovered via wild-type NK cells that circulated upon parabiosis as well as by administration of IFN-γ. In contrast, parabiotic restoration of NK cell deficiency in Irf2–/– mice failed to elevate MHCII expression on KCs. Furthermore, Irf2–/– KCs required several times higher amounts of IFN-γ to upregulate MHCII expression than Ifng–/– KCs. Thus, IRF-2 maintains steady-state MHCII expression on KCs by potentiating IFN-γ responses of KCs. Collectively, our current study revealed that IRF-2 plays critical roles in the establishment of the steady state hepatic macrophage system through negative and positive regulation of type I IFN and IFN-γ signaling, respectively.
- 6 May 2025
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 37 (9) , 543-553
Differential regulation of type I and II interferon signals by the transcription factor interferon regulatory factor-2 for the generation and function of macrophage populations in the liver
Two major macrophage populations in the steady-state liver, resident Kupffer cells (KCs) and monocyte-derived macrophages (MoMFs), contribute crucially to the unique physiological functions of the organ. Much remains to be learned, however, about how the differentiation and functions of these cell populations are regulated. We found here that Ly6C–MHCII+ MoMFs were severely reduced in mice lacking interferon (IFN) regulatory factor-2 (IRF-2) (Irf2–/– mice) but restored to the normal frequencies by introducing type I IFN receptor deficiency, indicating that IRF-2 supports MoMF differentiation through attenuating excess type I IFN signals. On the other hand, Irf2–/– KCs developed normally but lacked MHC class II (MHCII) expression. Similar MHCII deficiency in KCs in Il15–/– and Ifng–/– but not Rag1–/– mice pointed to the role for NK cell-derived IFN-γ. Indeed, MHCII expression on resident KCs in Ifng–/– mice was recovered via wild-type NK cells that circulated upon parabiosis as well as by administration of IFN-γ. In contrast, parabiotic restoration of NK cell deficiency in Irf2–/– mice failed to elevate MHCII expression on KCs. Furthermore, Irf2–/– KCs required several times higher amounts of IFN-γ to upregulate MHCII expression than Ifng–/– KCs. Thus, IRF-2 maintains steady-state MHCII expression on KCs by potentiating IFN-γ responses of KCs. Collectively, our current study revealed that IRF-2 plays critical roles in the establishment of the steady state hepatic macrophage system through negative and positive regulation of type I IFN and IFN-γ signaling, respectively.
- Open Access
- 25 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Synthetic short mRNA prevents metastasis via innate-adaptive immunity
Although most cancer deaths are caused by metastasis, there are no effective therapeutic approaches. This study describes the efficacy of a short synthetic mRNA (s-mRNA) designed by the sequence of non-vesicular extracellular IL1β-mRNA found in the pre-metastatic lung of tumor-bearing mice. The administration of s-mRNA inhibits murine lung metastasis by inducing the innate and adaptive immune systems. s-mRNA binds to ZC3H12D, an RNA-binding protein on natural killer cells and cytotoxic T lymphocytes. The ZC3H12D-s-mRNA complex translocated to the nucleus without being involved in translation. This process induces cytolytic activity and cell death in cancer cells without inducing a cytokine storm, and immune cells retain their antitumor activity. Although the antitumor activity of cytotoxic lymphocytes declines as the disease progresses in cancer patients, s-mRNA induces sustained high killing capacities of natural killer cells and cytotoxic T lymphocytes from colon cancer patients. Therefore, s-mRNA could be a breakthrough solution to prevent metastasis.
- 25 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessSynthetic short mRNA prevents metastasis via innate-adaptive immunity
Although most cancer deaths are caused by metastasis, there are no effective therapeutic approaches. This study describes the efficacy of a short synthetic mRNA (s-mRNA) designed by the sequence of non-vesicular extracellular IL1β-mRNA found in the pre-metastatic lung of tumor-bearing mice. The administration of s-mRNA inhibits murine lung metastasis by inducing the innate and adaptive immune systems. s-mRNA binds to ZC3H12D, an RNA-binding protein on natural killer cells and cytotoxic T lymphocytes. The ZC3H12D-s-mRNA complex translocated to the nucleus without being involved in translation. This process induces cytolytic activity and cell death in cancer cells without inducing a cytokine storm, and immune cells retain their antitumor activity. Although the antitumor activity of cytotoxic lymphocytes declines as the disease progresses in cancer patients, s-mRNA induces sustained high killing capacities of natural killer cells and cytotoxic T lymphocytes from colon cancer patients. Therefore, s-mRNA could be a breakthrough solution to prevent metastasis.
- 27 January 2023
- Published by Wiley in Genes to Cells
- Vol. 28 (3) , 226-236
Interleukin‐3‐dependent potentiation of IgE responsiveness in mouse basophils
Basophils produce interleukins (IL)‐4 in response to various stimuli and may contribute to type 2 immune responses to various infections and allergens. We found that resting basophils freshly isolated from mice produce IL‐4 in response to IL‐3 but not to high‐affinity Fc receptor (FcεRI) cross‐linking (CL), yet both required the immunoreceptor tyrosine‐based activation motif (ITAM) containing adaptor Fc receptor γ‐chain (FcRγ), while basophils activated in vitro by IL‐3 become responsive to FcεRI CL. Acquisition of responsiveness to FcεRI CL occurred upon infection with Trichinella spiralis or administration of superantigen. Because cultured basophils return to a quiescent state upon starvation with IL‐3 with surface FcεRI levels unchanged, this acquisition is reversible and probably reflects intracellular events requiring protein synthesis. Interestingly, similar activation‐associated acquisition was observed for responsiveness to other stimuli, including CD200R3 CL, which is known to signal via DAP‐12, and the allergen protease papain. This acquisition of responsiveness to FcεRI CL was inhibited by Jak inhibitor. Thus, the IL‐3 signal bifurcates downstream of Jak, into two distinct pathway, one leading to IL‐4 production and the other to render basophils competent to respond to stimuli dependent on ITAM‐containing adaptors DAP12 and FcRγ for IL‐4 production.
- 27 January 2023
- Published by Wiley in Genes to Cells
- Vol. 28 (3) , 226-236
Interleukin‐3‐dependent potentiation of IgE responsiveness in mouse basophils
Basophils produce interleukins (IL)‐4 in response to various stimuli and may contribute to type 2 immune responses to various infections and allergens. We found that resting basophils freshly isolated from mice produce IL‐4 in response to IL‐3 but not to high‐affinity Fc receptor (FcεRI) cross‐linking (CL), yet both required the immunoreceptor tyrosine‐based activation motif (ITAM) containing adaptor Fc receptor γ‐chain (FcRγ), while basophils activated in vitro by IL‐3 become responsive to FcεRI CL. Acquisition of responsiveness to FcεRI CL occurred upon infection with Trichinella spiralis or administration of superantigen. Because cultured basophils return to a quiescent state upon starvation with IL‐3 with surface FcεRI levels unchanged, this acquisition is reversible and probably reflects intracellular events requiring protein synthesis. Interestingly, similar activation‐associated acquisition was observed for responsiveness to other stimuli, including CD200R3 CL, which is known to signal via DAP‐12, and the allergen protease papain. This acquisition of responsiveness to FcεRI CL was inhibited by Jak inhibitor. Thus, the IL‐3 signal bifurcates downstream of Jak, into two distinct pathway, one leading to IL‐4 production and the other to render basophils competent to respond to stimuli dependent on ITAM‐containing adaptors DAP12 and FcRγ for IL‐4 production.
- 15 December 2022
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 35 (5) , 231-241
Interferon regulatory factor-2 is required for the establishment of the gut intraepithelial T-cell compartment
CD8αα + intestinal intraepithelial lymphocytes (iIELs) are known for their unique role in keeping the integrity of the intestinal epithelial barrier, but factors affecting the development of these cells have not been thoroughly understood. Here we found that the transcriptional regulator interferon regulatory factor-2 (IRF-2) plays a cell-intrinsic, indispensable role in establishing iIEL populations. CD8αα +, but not CD8αβ +, iIELs bearing TCRαβ or TCRγδ were severely reduced in numbers in mice lacking this factor (Irf2–/– mice). Moreover, the majority of residual CD8αα +TCRαβ + iIELs in these mice were immature as judged from their Thy1.2 high phenotype and inefficient T-bet expression. Thymic IEL precursors isolated from Irf2–/– mice failed to efficiently generate CD8αα +TCRαβ + and TCRγδ + IELs upon transfer in vivo and CD8αα +TCRαβ + cells in response to IL-15 in vitro. Double mutant mice lacking both IL-15 and IRF-2 showed an even more severe iIEL defect than in mice lacking IL-15 alone. Upon increasing agonistic TCR signal strength through OT-II TCR transgenesis, CD8αα +TCRαβ + iIELs became more abundant but remained immature on the Irf2–/– background. Our current observations thus revealed the unique bimodal role that IRF-2 plays in promoting not only generation of IEL progenitors in the thymus but also maturation of iIELs in the periphery in IL-15-dependent and -independent manners.
- 15 December 2022
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 35 (5) , 231-241
Interferon regulatory factor-2 is required for the establishment of the gut intraepithelial T-cell compartment
CD8αα + intestinal intraepithelial lymphocytes (iIELs) are known for their unique role in keeping the integrity of the intestinal epithelial barrier, but factors affecting the development of these cells have not been thoroughly understood. Here we found that the transcriptional regulator interferon regulatory factor-2 (IRF-2) plays a cell-intrinsic, indispensable role in establishing iIEL populations. CD8αα +, but not CD8αβ +, iIELs bearing TCRαβ or TCRγδ were severely reduced in numbers in mice lacking this factor (Irf2–/– mice). Moreover, the majority of residual CD8αα +TCRαβ + iIELs in these mice were immature as judged from their Thy1.2 high phenotype and inefficient T-bet expression. Thymic IEL precursors isolated from Irf2–/– mice failed to efficiently generate CD8αα +TCRαβ + and TCRγδ + IELs upon transfer in vivo and CD8αα +TCRαβ + cells in response to IL-15 in vitro. Double mutant mice lacking both IL-15 and IRF-2 showed an even more severe iIEL defect than in mice lacking IL-15 alone. Upon increasing agonistic TCR signal strength through OT-II TCR transgenesis, CD8αα +TCRαβ + iIELs became more abundant but remained immature on the Irf2–/– background. Our current observations thus revealed the unique bimodal role that IRF-2 plays in promoting not only generation of IEL progenitors in the thymus but also maturation of iIELs in the periphery in IL-15-dependent and -independent manners.
- 15 September 2022
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 209 (6) , 1173-1179
TAK1 Limits Death Receptor Fas-Induced Proinflammatory Cell Death in Macrophages
Fas, a member of the death receptor family, plays a central role in initiating cell death, a biological process crucial for immune homeostasis. However, the immunological and pathophysiological impacts to which enhanced Fas signaling gives rise remain to be fully understood. Here we demonstrate that TGF-β–activated kinase 1 (TAK1) works as a negative regulator of Fas signaling in macrophages. Upon Fas engagement with high concentrations of FasL, mouse primary macrophages underwent cell death, and, surprisingly, Fas stimulation led to proteolytic cleavage of gasdermin (GSDM) family members GSDMD and GSDME, a hallmark of pyroptosis, in a manner dependent on caspase enzymatic activity. Remarkably, TAK1-deficient macrophages were highly sensitive to even low concentrations of FasL. Mechanistically, TAK1 negatively modulated RIPK1 kinase activity to protect macrophages from excessive cell death. Intriguingly, mice deficient for TAK1 in macrophages (TAK1mKO mice) spontaneously developed tissue inflammation, and, more important, the emergence of inflammatory disease symptoms was markedly diminished in TAK1mKO mice harboring a catalytically inactive RIPK1. Taken together, these findings not only revealed an unappreciated role of TAK1 in Fas-induced macrophage death but provided insight into the possibility of perturbation of immune homeostasis driven by aberrant cell death.
- 15 September 2022
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 209 (6) , 1173-1179
TAK1 Limits Death Receptor Fas-Induced Proinflammatory Cell Death in Macrophages
Fas, a member of the death receptor family, plays a central role in initiating cell death, a biological process crucial for immune homeostasis. However, the immunological and pathophysiological impacts to which enhanced Fas signaling gives rise remain to be fully understood. Here we demonstrate that TGF-β–activated kinase 1 (TAK1) works as a negative regulator of Fas signaling in macrophages. Upon Fas engagement with high concentrations of FasL, mouse primary macrophages underwent cell death, and, surprisingly, Fas stimulation led to proteolytic cleavage of gasdermin (GSDM) family members GSDMD and GSDME, a hallmark of pyroptosis, in a manner dependent on caspase enzymatic activity. Remarkably, TAK1-deficient macrophages were highly sensitive to even low concentrations of FasL. Mechanistically, TAK1 negatively modulated RIPK1 kinase activity to protect macrophages from excessive cell death. Intriguingly, mice deficient for TAK1 in macrophages (TAK1mKO mice) spontaneously developed tissue inflammation, and, more important, the emergence of inflammatory disease symptoms was markedly diminished in TAK1mKO mice harboring a catalytically inactive RIPK1. Taken together, these findings not only revealed an unappreciated role of TAK1 in Fas-induced macrophage death but provided insight into the possibility of perturbation of immune homeostasis driven by aberrant cell death.
- 8 June 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 618, 93-99
Circulating T cells and resident non-T cells restrict type 2 innate lymphoid cell expansion in the small intestine
- 8 June 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 618, 93-99
Circulating T cells and resident non-T cells restrict type 2 innate lymphoid cell expansion in the small intestine
- 15 August 2019
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 203 (4) , 783-788
Cutting Edge: TAK1 Safeguards Macrophages against Proinflammatory Cell Death
TGF-β–activated kinase 1 (TAK1) is known to play vital roles for innate and adaptive immunity; however, little is known about its potential role in limiting biological responses such as inflammation. In this study, we report that macrophage TAK1 participates in negatively regulating inflammation by restraining proinflammatory cell death. Macrophages from TAK1-deficient mice underwent cell death in response to LPS and poly(I:C), which took place in a manner dependent on TLR/TRIF-induced active Caspase8-mediated cleavage of gasdermin D, known as an executioner of pyroptosis. Likewise, TNF-α induced Caspase8-dependent gasdermin D processing following cell death in TAK1-deficient macrophages. Importantly, we demonstrated that this type of proinflammatory macrophage death is linked to susceptibility to septic shock in mice lacking TAK1 in macrophages in a TNF-α–independent fashion. Taken together, our data revealed that TAK1 acts as a signaling checkpoint to protect macrophages from unique proinflammatory cell death, ensuring the maintenance of innate immune homeostasis.
- 15 August 2019
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 203 (4) , 783-788
Cutting Edge: TAK1 Safeguards Macrophages against Proinflammatory Cell Death
TGF-β–activated kinase 1 (TAK1) is known to play vital roles for innate and adaptive immunity; however, little is known about its potential role in limiting biological responses such as inflammation. In this study, we report that macrophage TAK1 participates in negatively regulating inflammation by restraining proinflammatory cell death. Macrophages from TAK1-deficient mice underwent cell death in response to LPS and poly(I:C), which took place in a manner dependent on TLR/TRIF-induced active Caspase8-mediated cleavage of gasdermin D, known as an executioner of pyroptosis. Likewise, TNF-α induced Caspase8-dependent gasdermin D processing following cell death in TAK1-deficient macrophages. Importantly, we demonstrated that this type of proinflammatory macrophage death is linked to susceptibility to septic shock in mice lacking TAK1 in macrophages in a TNF-α–independent fashion. Taken together, our data revealed that TAK1 acts as a signaling checkpoint to protect macrophages from unique proinflammatory cell death, ensuring the maintenance of innate immune homeostasis.
- 1 April 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 511 (2) , 350-355
Staphylococcal superantigen-like 12 activates murine bone marrow derived mast cells
- 1 April 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 511 (2) , 350-355
Staphylococcal superantigen-like 12 activates murine bone marrow derived mast cells
- Open Access
- 19 February 2019
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 31 (8) , 489-498
Generation of a common innate lymphoid cell progenitor requires interferon regulatory factor 2
Innate lymphoid cells (ILCs), composed of heterogeneous populations of lymphoid cells, contribute critically to immune surveillance at mucosal surfaces. ILC subsets develop from common lymphoid progenitors through stepwise lineage specification. However, the composition and temporal regulation of the transcription factor network governing such a process remain incompletely understood. Here, we report that deletion of the transcription factor interferon regulatory factor 2 (IRF-2), known also for its importance in the maturation of conventional NK cells, resulted in an impaired generation of ILC1, ILC2 and ILC3 subsets with lymphoid tissue inducer (LTi)-like cells hardly affected. In IRF-2-deficient mice, PD-1hi ILC precursors (ILCPs) that generate these three ILCs but not LTi-like cells were present at normal frequency, while their sub-population expressing high amounts of PLZF, another marker for ILCPs, was severely reduced. Notably, these IRF-2-deficient ILCPs contained normal quantities of PLZF-encoding Zbtb16 messages, and PLZF expression in developing invariant NKT cells within the thymus was unaffected in these mutant mice. These results point to a unique, cell-type selective role for IRF-2 in ILC development, acting at a discrete step critical for the generation of functionally competent ILCPs.
- 19 February 2019
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 31 (8) , 489-498
Open AccessGeneration of a common innate lymphoid cell progenitor requires interferon regulatory factor 2
Innate lymphoid cells (ILCs), composed of heterogeneous populations of lymphoid cells, contribute critically to immune surveillance at mucosal surfaces. ILC subsets develop from common lymphoid progenitors through stepwise lineage specification. However, the composition and temporal regulation of the transcription factor network governing such a process remain incompletely understood. Here, we report that deletion of the transcription factor interferon regulatory factor 2 (IRF-2), known also for its importance in the maturation of conventional NK cells, resulted in an impaired generation of ILC1, ILC2 and ILC3 subsets with lymphoid tissue inducer (LTi)-like cells hardly affected. In IRF-2-deficient mice, PD-1hi ILC precursors (ILCPs) that generate these three ILCs but not LTi-like cells were present at normal frequency, while their sub-population expressing high amounts of PLZF, another marker for ILCPs, was severely reduced. Notably, these IRF-2-deficient ILCPs contained normal quantities of PLZF-encoding Zbtb16 messages, and PLZF expression in developing invariant NKT cells within the thymus was unaffected in these mutant mice. These results point to a unique, cell-type selective role for IRF-2 in ILC development, acting at a discrete step critical for the generation of functionally competent ILCPs.